Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page
- Check5 days agoChange DetectedThe page has updated its time slot availability by adding new dates in June 2025 while removing previous dates from April 2025.SummaryDifference0.6%
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check63 days agoChange DetectedThe page has been updated to reflect a new version number, changing from v2.15.0 to v2.15.2, and the phrasing regarding the last update has been clarified.SummaryDifference0.1%
- Check70 days agoChange DetectedThe webpage has been updated to reflect a new phase 2 study involving Ipilimumab and Nivolumab for treating HPV-positive oropharyngeal carcinoma, with a new estimated last update date of April 2025.SummaryDifference2%
Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.